Lipocine Revenue, Profits - LPCN Annual Income Statement

Add to My Stocks
$1.54 $0.02 (1.32%) LPCN stock closing price Sep 21, 2018 (Closing)

Looking at financial statements, along with the Lipocine stock price, it's management, its economic moat, and industry competitors forms an important part of fundamental analysis. The income statement gives the investor an understanding of the topline or revenue and bottomline or profit numbers of the company and helps investors evaluate if a company has been growing or not. Like any other income statement, the LPCN income statement also itemizes revenue/sales, operating expenses, and profits/bottomline for a quarter or year and reflects a YOY revenue decline of 0 when compared to the same period in the past. One also needs to look at Lipocine assets, operating expenses and Lipocine free cash flow. The Lipocine profit and loss statement shows revenue of $- for 2017. Revenue has decreased by 0 YOY for LPCN stock.

View revenue and profit details for latest and last 10 financial years.
show more
Quarterly
Annual
View Previous Years
View Next Years
Fiscal year is Jan - Dec2017201620152014201320122011
Lipocine Revenues or Net Sales
-------
Cost Of Goods Sold (COGS)-------
Lipocine Gross Profit
-------
Research & Development Expense11M8.07M12.58M15.47M5.12M--
Selling General & Admin Expense10.21M11.11M5.8M5M5.56M--
Income Before Depreciation Depletion Amortization-21.21M-19.18M-18.38M-20.48M-10.68M-0.07M-0.01M
Depreciation Depletion Amortization-------
Non Operating Income-------
Interest Expense-------
Lipocine Pretax Income
-20.98M-18.97M-18.2M-20.37M-10.64M-0.07M-0.01M
Provision for Income Taxes-----0.05M--
MinorityInterest-------
Investment Gains Losses-------
Other Income-------
Income Before Extraordinaries & Disc Operations-20.98M-18.97M-18.2M-20.37M-10.59M-0.07M-0.01M
Extraordinary Items & Discontinued Operations-------
Lipocine Profit/ Loss (Net Income)
-20.98M-18.97M-18.2M-20.37M-10.59M-0.07M-0.01M
Average Shares used to compute Diluted EPS20.05M18.26M16.47M12.77M---
Average Shares used to compute Basic EPS20.05M18.26M16.47M12.77M---
Income Before Nonrecurring Items-20.98M-18.59M-18.21M-20.37M---
Income from Nonrecurring Items--0.39M-----
Lipocine Earnings Per Share Basic Net
-1.05-1.04-1.11-1.60-0.84--
Lipocine Earnings Per Share Diluted Net
-1.05-1.04-1.11-1.60---
EPS Diluted Before Nonrecurring Items-1.05-1.02-1.11-1.60---
Preferred Dividends Acc Pd-------
Dividends Common-------
Dividend Per Share Common0.000.000.000.000.000.000.00
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

Lipocine stock analysis involves checking at least a few of the important things like:

  • Revenue: The money received by selling of goods or services comes under this line item. A YoY growth - See: Lipocine revenue chart implies that the company is growing. It has not been the case with Lipocine. One must look at stocks with increasing revenues, and stay away from stocks whose revenues or sales are declining.
  • Bottom line: Most businesses like Lipocine try to grow their profits by growing their topline and by increasing their operating efficiency. A healthy bottom line growth implies a good investment.

The income statement is also called the profit and loss statement. Apart from the LPCN income statement, one can check the Lipocine historical stock prices to check how the price has moved with time.

Lipocine Income Statement - Key Financial Ratios